Awards and Prizes
British Council for Prevention of Blindness (BCPB) Grants available
BCPB aims to target the most resource deprived populations for benefit through the funding of research into blindness prevention. Low and lower middle income World Bank categories are regarded by BCPB as the areas in greatest need. Applications for work in upper middle income countries may exceptionally be supported, provided the major impact of the research is
Fight for Sight – John Lee, The Royal College of Ophthalmologists Award
This primer award of up to £60,000 is on offer from Fight for Sight in partnership with The Royal College of Ophthalmologists in remembrance of past president John Lee. The award is only open for RCOphth members and aims to provide funding to support the initial stages in a trainee ophthalmologist’s careers to equip those
BOSU Surveillance Study Bursary
With the kind support from The Red Trust and the Ross Foundation, the BOSU is once again offering three research bursaries of £6000 to support ophthalmologists in training to undertake an epidemiological study of a rare eye condition through the British Ophthalmological Surveillance Unit or the Scottish Ophthalmological Surveillance Unit. The objective for these awards
BMA Information Fund 2017
The BMA Information Fund provides health information and educational materials to health-focused organisations in developing countries and low resource settings. The fund is now open for application until 5pm on Thursday 14 September 2017 or when 100 applications are received. Prospective applicants are encouraged to apply as soon as possible. Successful applicants will be informed by 28 November
NICE Launches a competition for developers of healthcare technologies
NICE Scientific Advice has launched a competition for small or medium sized companies, charities and academic research groups, who are developing transformative products that have the potential to change patients’ lives and/or save the NHS money. The NICE AdviSeME Prize is open to products (pharmaceuticals, devices, diagnostic test/tools, cell/gene therapies, healthcare apps) in the early clinical stages